Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. - Wikidata - wikimedia - TriplyDB

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

http://www.wikidata.org/entity/Q33763653

about

Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship Immune regulation of bone metastasis Radiotherapy and the tumor stroma: the importance of dose and fractionation Regulatory dendritic cells in the tumor immunoenvironment Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity State-of-the-art of regulatory dendritic cells in cancer Immune heterogeneity in neuroinflammation: dendritic cells in the brain Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells Regulatory dendritic cells: there is more than just immune activation Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses Anti-tumor immunity: myeloid leukocytes control the immune landscape Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics Coordinated regulation of myeloid cells by tumours Cancer: A dendritic-cell brake on antitumour immunity The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue Fluorescent-tilmanocept for tumor margin analysis in the mouse model.Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming.FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2.Influence of synthetic superparamagnetic iron oxide on dendritic cells.Complexity and challenges in defining myeloid-derived suppressor cells In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer Leukocyte populations and IL-6 in the tumor microenvironment of an orthotopic colorectal cancer model Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.The migration of synthetic magnetic nanoparticle labeled dendritic cells into lymph nodes with optical imaging.In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.

P2860

Q27000087-2C596B56-3F36-46EE-B856-D2622EF1E5CE Q27005871-AF48679F-8224-420B-B9B0-888B2ECBF596 Q27022685-F381627C-B5AF-44FB-89A5-D4FABCEA5712 Q27023084-36226322-E426-41DE-A11F-6C4DF8C86F0D Q27311601-21724712-5287-427D-A6D3-C05E2E15966F Q28071357-AF1E0AA4-174D-498D-9B70-8946A63BEDD8 Q28116224-3C53BB2B-544F-4507-B9DD-44F6F1090F91 Q28304923-5659E528-BEF2-48D5-B3B2-464132C19EBE Q28383942-E627A969-71DA-48F2-8741-EC152ACB988A Q28385127-7B573B6A-3BB8-46A2-A773-FBA10CD12A11 Q28386614-BD3BFA36-5E14-40B9-8857-B5BED716C90B Q28386617-A993D821-F807-46F5-9C9B-96C17EA63825 Q28388235-73D7C32E-E333-4B67-ACC1-7269EC02BD90 Q28390368-172CACE9-8783-4458-9ED3-EE6B4AF682E8 Q28390573-FB765DBB-CB5E-43B4-932D-F52DA8DFD4BE Q28392156-7F7DDC22-7B44-4307-B1F3-D160BAD7EA27 Q28392626-52D96521-8BF5-459D-BCF9-3F75E214F53F Q28393614-FDB9F289-C333-43E4-B9F7-35345D977B5A Q28395157-23E086FE-ADEE-4899-8EC6-58B0D80DF641 Q28397758-0206008F-91BE-488D-A4B3-218FD3814FBF Q29248715-52F3AEF5-003C-4C16-A123-7458691EAC24 Q30438965-F6555E6A-E279-460D-BC84-7F966A7951A9 Q31139529-51F87FEF-5E2B-4318-BA53-88181ABFCD9C Q34363958-B608B09B-BEF8-44E7-82C6-3B13EA882CBD Q34525738-FBDF12D3-2B6D-4CDD-8880-22E925E480DE Q34755205-BE50787B-1883-430A-874E-23C3BC6F6BB7 Q35175098-8AFB5BAA-07FC-4CF2-9DF2-B43BBBFB08A3 Q35254464-D440A62D-31FC-49C4-98F4-03EE2ABB3A40 Q35509317-A3BF9E45-A381-4DAA-85F5-F737996DB8D7 Q35556913-EC6A7EB2-B094-4985-BCB2-36B7163344CE Q35721553-2CAFDCC2-83AE-48A0-BD4C-E63D2E059FB6 Q35851748-033E3469-8348-4A14-9A97-20A51A494048 Q36821053-7980459A-B9FF-4724-9E18-0BEA02603CC0 Q36896764-755EF8FE-48D6-4889-850E-9D746DABF1C6 Q36949584-60042A43-E873-4ECD-B907-CF4450384DC8 Q37017472-E7AA33CE-70F0-437B-A442-3D44C5BAEB70 Q37196532-55553D4B-4763-45A9-B935-E7BF00BBDD9B Q37225631-F7C9A233-5895-48C1-9CE3-D124C0509947 Q37369512-660A99E4-BB76-4362-8BFC-A6D106ED959C Q37670779-FA99DFFC-8987-4400-940A-6F552F048678

P2860

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

http://www.wikidata.org/entity/Q33763653

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Tumor-infiltrating regulatory ...... ion via L-arginine metabolism.

@ast

Tumor-infiltrating regulatory ...... ion via L-arginine metabolism.

@en

type

label

Tumor-infiltrating regulatory ...... ion via L-arginine metabolism.

@ast

Tumor-infiltrating regulatory ...... ion via L-arginine metabolism.

@en

prefLabel

Tumor-infiltrating regulatory ...... ion via L-arginine metabolism.

@ast

Tumor-infiltrating regulatory ...... ion via L-arginine metabolism.

@en

P1433

Q33763653-52612453-4C2D-40C9-BA9A-7FA31ABD681A

P1476

Q33763653-182426D8-4E61-4B25-862C-1BA1D37CB2AF

P2093

Q33763653-2B5D61F6-A00E-4A47-B4F6-E0BE2049F589

Q33763653-3E3A0D11-7D57-4234-B10D-6359A002A949

Q33763653-755E7AC6-483A-440C-9337-B99FF3EE59CF

Q33763653-938F923D-830A-4CB6-837F-9CF74040C3F7

Q33763653-9EEF5DA5-B622-4A44-82EC-CA7BFEEEF830

Q33763653-F8E49913-3670-463D-9B6F-FE73980E68DF

P2860

Q33763653-0124C852-1D03-40FA-9F08-7B1D9273CCEE

Q33763653-039ABAC0-6B37-475A-B984-37D3644E8821

Q33763653-097F21EF-07BE-4FFB-B9B3-4B45E2A1847E

Q33763653-0F724650-A976-4CF8-B9D5-5CA7769FD453

Q33763653-0FF587E3-0929-4DAB-8504-96E869C7E1E0

Q33763653-145B468F-9E4A-44AB-AF1E-238C3DA01C1C

Q33763653-1919CAA6-5B8D-49DC-BAA4-43C4F4D995DD

Q33763653-1B908261-63CB-4F48-9848-171A847480BE

Q33763653-24BAC4BD-CB79-46A2-A421-F914A193E40D

Q33763653-24F871DF-F6F0-453A-BAFA-B06436406C78

P304

Q33763653-761F7AFC-2585-49EF-9D2A-EA1BAD47B97D

P31

Q33763653-032D57AC-9CB2-40FD-B021-092507165E7D

P356

Q33763653-1A369DD7-3D6B-4257-9D84-3CBBADB2D59D

P407

Q33763653-027972E6-88A8-4B76-B810-172F57627C80

P433

Q33763653-82DA5A04-8864-4254-95F0-B2B6AA5EAE13

P478

Q33763653-253EC6AB-93CC-400C-8E6D-4BE069D1C7A4

P50

Q33763653-1F3FBE32-BAF9-4E5F-A0E8-E66B019C2F9B

P577

Q33763653-5BF5026D-1E6F-4975-A2C8-43986A0B098E

P5875

Q33763653-FCFD5A0F-9A1A-41E5-B591-26EA04C19064

P698

Q33763653-A662F57A-B1B5-4F4F-B025-64988BADA489

P932

Q33763653-BFEC0423-5AE6-4F5C-8346-9EA3C64FACE8

P356

0008-5472.CAN-08-2826

P1433

Cancer Research

P1476

Tumor-infiltrating regulatory ...... tion via L-arginine metabolism

@en

P2093

Augusto C Ochoa

http://www.w3.org/2001/XMLSchema#string

Jovanny Zabaleta

http://www.w3.org/2001/XMLSchema#string

Leigh A O'Mara

http://www.w3.org/2001/XMLSchema#string

Lyse A Norian

http://www.w3.org/2001/XMLSchema#string

Paul M Allen

http://www.w3.org/2001/XMLSchema#string

Paulo C Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of immune responses by L-arginine metabolism

The role of myeloid cells in the promotion of tumour angiogenesis

IDO expression by dendritic cells: tolerance and tryptophan catabolism

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Immunosuppressive strategies that are mediated by tumor cells

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Rapid maturation of effector T cells in tumors, but not lymphoid organs, during tumor regression.

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

L-arginine availability regulates T-lymphocyte cell-cycle progression

Mechanisms and functional significance of tumour-induced dendritic-cell defects.

P304

3086-3094

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-2826

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24207317

http://www.w3.org/2001/XMLSchema#string

P698

19293186

http://www.w3.org/2001/XMLSchema#string

P932

2848068

http://www.w3.org/2001/XMLSchema#string